Document 3265 DOCN M94A3265 TI Serodiagnostic profiles of HIV-1 from Nigeria. DT 9412 AU Offor E; Mclane MF; Trujillo R; Kanki P; Essex M; Dept. Cancer Biology, Harvard School of Public Health, Boston, MA; 02115. SO Int Conf AIDS. 1994 Aug 7-12;10(1):115 (abstract no. PA0078). Unique Identifier : AIDSLINE ICA10/94369310 AB OBJECTIVE: To compare the serum antibody profiles of a Nigerian HIV-1 viral isolate with those of an African (Congo) and a North American isolate (USA). METHOD: Three HIV-1 antigens, USA type IIIB, a Congolese isolate and a Nigerian isolate (N-4), were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. N-4 was isolated from peripheral blood lymphocytes from a Nigerian AIDS patient. Sera from 75 HIV-1 positive Nigerians were reacted with each of the HIV-1 strains on Western blot. Radioimmunoprecipitation analysis (RIPA) was performed using a positive T cell lysate of N-4 and a negative T cell lysate (control) to demonstrate the envelope and core specific bands. RESULTS: A majority of sera showed reactivity to Gag and Pol gene products of all three isolates. A few positive sera reacted with all bands, including gp120 and gp160. Reactivity to HIV-1 gp120 was confirmed by RIPA on N-4. Cross-reactivity was observed between IIIB and some Nigerian sera. CONCLUSION: The Nigerian isolate had relatively similar antibody reactivity to the Congolese strain. It appears to be a prototype African HIV-1 isolate. Further characterization of the virus and the observed cross reactivity is ongoing at this time. DE AIDS Serodiagnosis Comparative Study Congo Cross Reactions Gene Products, env/IMMUNOLOGY Gene Products, gag/IMMUNOLOGY Gene Products, pol/IMMUNOLOGY Human HIV Antibodies/*BLOOD HIV Envelope Protein gp120/IMMUNOLOGY HIV Infections/*IMMUNOLOGY/MICROBIOLOGY HIV-1/*IMMUNOLOGY/ISOLATION & PURIF Lymphocytes/MICROBIOLOGY Nigeria Protein Precursors/IMMUNOLOGY Species Specificity United States MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).